HDAC9 and cancer: This link between RA signaling and HDAC inhibition is best characterized in cancer cells, where HDIs alter gene expression and restore sensitivity to retinoid treatment (Jiang et al., 2008; Rettig et al., 2015; Touma et al., 2005; Wang et al., 2005).